|
Market Closed -
London S.E.
19:35:12 20/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.250 GBX | 0.00% |
|
0.00% | +21.62% |
| 10-20 | WINNERS & LOSERS: Ixico beats expectations; Shearwater wins deal | AN |
| 10-15 | Truetide Unit, VosBio Complete Phase 2 of Development Program for Early Lung Cancer Detection | MT |
Company Valuation: Truetide plc
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 27 | 9.273 | 4.301 | 4.046 | 3.186 | 1.256 |
| Change | - | -65.66% | -53.61% | -5.93% | -21.26% | -60.59% |
| Enterprise Value (EV) 1 | 24.86 | 7.379 | 3.366 | 2.304 | 3.123 | 1.105 |
| Change | - | -70.32% | -54.38% | -31.56% | 35.52% | -64.61% |
| P/E | 2x | 6.29x | 2.52x | -0.56x | -2.92x | -2.86x |
| PBR | 10.5x | 1.4x | 0.41x | 1.19x | 1.37x | 0.57x |
| PEG | - | -0.1x | -0.51x | 0x | 0x | 0x |
| Capitalization / Revenue | 3.54x | 3.16x | 1.35x | -0.7x | -7.73x | 11.3x |
| EV / Revenue | 3.26x | 2.51x | 1.06x | -0.4x | -7.58x | 9.97x |
| EV / EBITDA | 4.61x | 4.73x | 1.44x | -0.28x | -2.78x | -2.56x |
| EV / EBIT | 4.62x | 4.77x | 1.44x | -0.28x | -2.78x | -2.56x |
| EV / FCF | 6.02x | 9.4x | 1.85x | -0.45x | -4.64x | -6.94x |
| FCF Yield | 16.6% | 10.6% | 54.1% | -221% | -21.6% | -14.4% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.3533 | 0.0282 | 0.0268 | -0.1138 | -0.0171 | -0.005599 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 7.63 | 2.937 | 3.179 | -5.74 | -0.412 | 0.1108 |
| EBITDA 1 | 5.395 | 1.561 | 2.34 | -8.207 | -1.122 | -0.4319 |
| EBIT 1 | 5.384 | 1.548 | 2.34 | -8.207 | -1.122 | -0.432 |
| Net income 1 | 13.94 | 1.454 | 1.585 | -7.249 | -1.089 | -0.425 |
| Net Debt 1 | -2.143 | -1.894 | -0.9349 | -1.742 | -0.0637 | -0.1506 |
| Reference price 2 | 0.7050 | 0.1775 | 0.0675 | 0.0635 | 0.0500 | 0.0160 |
| Nbr of stocks (in thousands) | 38,297 | 52,240 | 63,723 | 63,723 | 63,723 | 78,473 |
| Announcement Date | 6/18/21 A | 6/15/22 A | 7/5/23 A | 6/21/24 A | 7/10/25 A | 7/1/26 A |
1GBP in Million2GBP
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 2.31M | ||
| 20.92x | 5.7x | 12.31x | 2.08% | 170B | ||
| 12.94x | 3.15x | - | 2.76% | 133B | ||
| 15.13x | 7.06x | - | 1.63% | 95.04B | ||
| 18.61x | 6.65x | 11.84x | 4.59% | 88.61B | ||
| 17.68x | 10.79x | 16.67x | 0.88% | 78.99B | ||
| 19.93x | 12.49x | 21.69x | 4.09% | 78.34B | ||
| 11.56x | 4.57x | - | 2.26% | 42.28B | ||
| 10.37x | 1.51x | 4.7x | 1.4% | 41.7B | ||
| Average | 15.89x | 6.49x | 13.44x | 2.46% | 81B | |
| Weighted average by Cap. | 16.82x | 6.50x | 13.88x | 2.51% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BRH Stock
- Valuation Truetide plc
Select your edition
All financial news and data tailored to specific country editions
















